Jennifer A Muszynski1, Ryan Nofziger, Kristin Greathouse, Jyotsna Nateri, Lisa Hanson-Huber, Lisa Steele, Kathleen Nicol, Jonathan I Groner, Gail E Besner, Corey Raffel, Susan Geyer, Osama El-Assal, Mark W Hall. 1. *Pediatric Critical Care Medicine, Department of Pediatrics, and †The Research Institute, Nationwide Children's Hospital, Columbus, Ohio; ‡Critical Care Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio; §Department of Pathology, Nationwide Children's Hospital, Columbus, Ohio; and ║Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio; ¶Department of Neurological Surgery, University of California, San Francisco, San Francisco, California; and **Division of Hematology, The Ohio State University College of Medicine, Columbus; ††Emergency Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio.
Abstract
BACKGROUND: Critical injury has been associated with reduction in innate immune function in adults, with infection risk being related to degree of immune suppression. This relationship has not been reported in critically injured children. HYPOTHESIS: Innate immune function will be reduced in critically injured children, and the degree of reduction will predict the subsequent development of nosocomial infection. METHODS: Children (≤18 years old) were enrolled in this longitudinal, prospective, observational, single-center study after admission to the pediatric intensive care unit following critical injury, along with a cohort of outpatient controls. Serial blood sampling was performed to evaluate plasma cytokine levels and innate immune function as measured by ex vivo lipopolysaccharide-induced tumor necrosis factor α (TNF-α) production capacity. RESULTS: Seventy-six critically injured children (and 21 outpatient controls) were enrolled. Sixteen critically injured subjects developed nosocomial infection. Those subjects had higher plasma interleukin 6 and interleukin 10 levels on posttrauma days 1-2 compared with those who recovered without infection and outpatient controls. Ex vivo lipopolysaccharide-induced TNF-α production capacity was lower on posttrauma days 1-2 (P = 0.006) and over the first week following injury (P = 0.04) in those who went on to develop infection. A TNF-α response of less than 520 pg/mL at any time in the first week after injury was highly associated with infection risk by univariate and multivariate analysis. Among transfused children, longer red blood cell storage age, not transfusion volume, was associated with lower innate immune function (P < 0.0001). Trauma-induced innate immune suppression was reversible ex vivo via coculture of whole blood with granulocyte-macrophage colony-stimulating factor. CONCLUSIONS: Trauma-induced innate immune suppression is common in critically injured children and is associated with increased risks for the development of nosocomial infection. Potential exacerbating factors, including red blood cell transfusion, and potential therapies for pediatric trauma-induced innate immune suppression are deserving of further study.
BACKGROUND:Critical injury has been associated with reduction in innate immune function in adults, with infection risk being related to degree of immune suppression. This relationship has not been reported in critically injured children. HYPOTHESIS: Innate immune function will be reduced in critically injured children, and the degree of reduction will predict the subsequent development of nosocomial infection. METHODS:Children (≤18 years old) were enrolled in this longitudinal, prospective, observational, single-center study after admission to the pediatric intensive care unit following critical injury, along with a cohort of outpatient controls. Serial blood sampling was performed to evaluate plasma cytokine levels and innate immune function as measured by ex vivo lipopolysaccharide-induced tumornecrosis factor α (TNF-α) production capacity. RESULTS: Seventy-six critically injured children (and 21 outpatient controls) were enrolled. Sixteen critically injured subjects developed nosocomial infection. Those subjects had higher plasma interleukin 6 and interleukin 10 levels on posttrauma days 1-2 compared with those who recovered without infection and outpatient controls. Ex vivo lipopolysaccharide-induced TNF-α production capacity was lower on posttrauma days 1-2 (P = 0.006) and over the first week following injury (P = 0.04) in those who went on to develop infection. A TNF-α response of less than 520 pg/mL at any time in the first week after injury was highly associated with infection risk by univariate and multivariate analysis. Among transfused children, longer red blood cell storage age, not transfusion volume, was associated with lower innate immune function (P < 0.0001). Trauma-induced innate immune suppression was reversible ex vivo via coculture of whole blood with granulocyte-macrophage colony-stimulating factor. CONCLUSIONS:Trauma-induced innate immune suppression is common in critically injured children and is associated with increased risks for the development of nosocomial infection. Potential exacerbating factors, including red blood cell transfusion, and potential therapies for pediatric trauma-induced innate immune suppression are deserving of further study.
Authors: Jeffrey A Claridge; Robert G Sawyer; Andrew M Schulman; Elizabeth C McLemore; Jeffrey S Young Journal: Am Surg Date: 2002-07 Impact factor: 0.688
Authors: Sascha Flohé; Sven Lendemans; Fritz-Ulrich Schade; Ernst Kreuzfelder; Christian Waydhas Journal: Intensive Care Med Date: 2003-11-07 Impact factor: 17.440
Authors: Sascha Flohé; Sven Lendemans; Christian Selbach; Christian Waydhas; Marcus Ackermann; F Ulrich Schade; Ernst Kreuzfelder Journal: Crit Care Med Date: 2003-10 Impact factor: 7.598
Authors: Mark W Hall; Kristin C Greathouse; Rajan K Thakkar; Eric A Sribnick; Jennifer A Muszynski Journal: Pediatr Clin North Am Date: 2017-08-18 Impact factor: 3.278
Authors: Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen Journal: Pediatr Crit Care Med Date: 2017-03 Impact factor: 3.624
Authors: Jeffrey S Upperman; John C Bucuvalas; Felicia N Williams; Bruce A Cairns; Charles S Cox; Allan Doctor; Robert F Tamburro Journal: Pediatr Crit Care Med Date: 2017-03 Impact factor: 3.624
Authors: Monty B Mazer; Charles C Caldwell; Jodi Hanson; Daniel Mannion; Isaiah R Turnbull; Anne Drewry; Dale Osborne; Andrew Walton; Tessa Blood; Lyle L Moldawer; Scott Brakenridge; Kenneth E Remy; Richard S Hotchkiss Journal: J Immunol Date: 2020-11-25 Impact factor: 5.422
Authors: Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski Journal: Transfusion Date: 2018-01-30 Impact factor: 3.157
Authors: Sam Davila; E Scott Halstead; Mark W Hall; Allan Doctor; Russell Telford; Richard Holubkov; Joseph A Carcillo; Gregory A Storch Journal: Pediatr Crit Care Med Date: 2018-01 Impact factor: 3.624